Chemical giant Bayer says it “remains on a path of growth” as sales increased 11.5% in the third quarter compared to the same period in 2011. Sales in Q3 were €9.7bn (£7.8bn), an increase of 11.5% or 5.5% when accounting for currency and portfolio adjustments. Ebit before special items increased by 1.7% to €1.19bn Ebitda before special items was up 2.2% to €1.85bn. Overall, however, Bayer performed successfully in the third quarter, so is still expecting a currency- and portfolio-adjusted sales increase in 2012 of 4-5% compared to 2011. That would result in group of about €39-40bn.